Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. DPZ
2. NVDA
3. BAC
4. GS
5. ACI
6. DRS
7. JPM
8. AVAV
9. UNH
10. ORCL

Go back to Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

Pfizer (PFE) PT Raised to $33 at Goldman Sachs

October 30, 2024 6:16 AM EDT

Goldman Sachs analyst Chris Shibutani raised the price target on Pfizer (NYSE: PFE) to $33.00 (from $32.00) while maintaining a Buy rating.

The analyst comments "Despite an impressive headline beat and raise, PFE shares underperformed on the day (-1.4% vs. -0.3% XLV). The 3Q beat was... More

Pfizer (PFE) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY24 Guidance

October 29, 2024 6:46 AM EDT

Pfizer (NYSE: PFE) reported Q3 EPS of $1.06, $0.44 better than the analyst estimate of $0.62. Revenue for the quarter came in at $17.7 billion versus the consensus estimate of $14.92 billion.

GUIDANCE:

Pfizer sees FY2024 EPS of $2.75-$2.95, versus the consensus of $2.65. Pfizer sees... More